Function and diagnostic value of Anosmin-1 in gastric cancer progression. - Wikidata - awgldk - TriplyDB

Function and diagnostic value of Anosmin-1 in gastric cancer progression.

Function and diagnostic value of Anosmin-1 in gastric cancer progression.

http://www.wikidata.org/entity/Q38844030

about

Molecular mechanisms of peritoneal dissemination in gastric cancer Prognostic relevance of SAMSN1 expression in gastric cancer Expression of regulatory factor X1 can predict the prognosis of breast cancer Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy Study on molecular mechanism of ANOS1 promoting development of colorectal cancer.FBXO50 Enhances the Malignant Behavior of Gastric Cancer Cells.GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer.Epigenetic suppression of the immunoregulator MZB1 is associated with the malignant phenotype of gastric cancer.Potential Biomarkers in Diagnosis of Human Gastric Cancer.Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma.The role of TFPI2 hypermethylation in the detection of gastric and colorectal cancer.FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer.Neurotrophin Receptor-Interacting Melanoma Antigen-Encoding Gene Homolog is Associated with Malignant Phenotype of Gastric Cancer.The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer.Proposal of the Coagulation Score as a Predictor for Short-Term and Long-Term Outcomes of Patients with Resectable Gastric Cancer.Tumor Infiltrative Pattern Predicts Sites of Recurrence After Curative Gastrectomy for Stages 2 and 3 Gastric Cancer.Integrated multigene expression panel to prognosticate patients with gastric cancer.A novel dual-marker expression panel for easy and accurate risk stratification of patients with gastric cancer.Impact of energy restriction during late gestation on the muscle and blood transcriptome of beef calves after preconditioning

P2860

Q26738538-FC3677B8-9E98-492A-BEBF-2BE319CAE620 Q30008786-23FF1244-6DDB-4A9A-850F-C8C9AC921D06 Q33751079-D1F28A7C-96DE-40BA-9458-23AB940DDF67 Q37046429-2E6F5B19-3664-4D7C-805E-8E2857A6BF6A Q37205585-CAB82C96-EC6A-4CEA-A68B-07C088F09E70 Q37588076-98A33FF4-08EC-4138-9CA0-D33AD54815FC Q38602210-3A6E0672-7817-48EA-9D97-3412135DC56A Q38701768-2E601480-421B-4CE7-B48B-6467F8FBCC52 Q38717805-8290EABF-BB63-4E61-8717-0719E3609327 Q38755728-D22360FC-AF14-45A6-AC24-28234D96602F Q38757877-AB6B2DDC-59C1-4955-8554-2228E801F1E5 Q40061212-D5E4E2F2-191F-4B22-9AF0-C98120923B32 Q46123774-A4ADCE16-5CB5-4FFD-BF1B-43A1790AB0E9 Q48961576-4A8FCB87-27FE-4608-A709-0D4879B95FA1 Q51671379-7D50C410-0EB9-448D-87D9-D79B53A0382C Q53026533-E1EF03CB-8ADB-4DA2-A9FC-9DE6CF700480 Q53033345-E750B02F-CAC9-44E5-B4E5-A7B4A9D61098 Q53183755-F22FAAA3-F19C-4452-A834-F040B06B23A2 Q55280375-2499630B-3AE4-4F03-84A7-C208C76FA061 Q55322124-54944367-F0C9-41DA-8822-F441B59D752D Q58698420-B9067CF4-9665-4DF7-8CC6-0BCD1FF1E273

P2860

Function and diagnostic value of Anosmin-1 in gastric cancer progression.

http://www.wikidata.org/entity/Q38844030

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Function and diagnostic value of Anosmin-1 in gastric cancer progression.

@en

type

label

Function and diagnostic value of Anosmin-1 in gastric cancer progression.

@en

prefLabel

Function and diagnostic value of Anosmin-1 in gastric cancer progression.

@en

P1433

Q38844030-05C672F2-DC2C-4B27-877D-C2A68A9310A7

P1476

Q38844030-EB22DE71-ECC6-445C-8DF1-9840BD4B4C2D

P2093

Q38844030-1F4AA548-4331-46EA-A3BB-1202C70CD5D3

Q38844030-238D3E32-91F3-4B7D-B102-96965567FB20

Q38844030-3353B796-702F-4316-A5C8-50CA9BC769CD

Q38844030-37A8D6AC-E85B-4F1B-8C7E-A31DE436D763

Q38844030-57F11D31-9894-4502-890D-ED9853045AC1

Q38844030-65DBBD43-1E0D-4105-8C0B-B95D66155213

Q38844030-7AE43ED0-15EC-403B-ADE7-05535491DF2E

Q38844030-8D97FB67-0E61-42C9-95C6-74C75B60CC7A

Q38844030-A89CDD29-96A9-43EB-B2B4-84FC6FD3FA95

Q38844030-B505DC48-3179-4351-96E1-118B81DE0C06

P2860

Q38844030-08E5D32A-2AAD-4BD2-8A53-07C32B1EA1E4

Q38844030-139424D6-C3F0-4DD2-B41C-EA685306FB7E

Q38844030-18195EDB-7E77-4632-97E0-C4E961E812F9

Q38844030-19D76795-86A7-432C-8903-652F0525C596

Q38844030-1EC91817-D07E-4A2A-A883-8F0B1E9FDD27

Q38844030-20703247-8B88-493C-87A3-E93B8E43E030

Q38844030-317E5C0B-6503-458E-85D3-93CBDED5031D

Q38844030-38F44719-D967-4BCA-9CEB-0FEE05CF3D04

Q38844030-471F086F-2018-4D68-BB65-CC85566740DD

Q38844030-4E6D08A5-E4CE-4D64-8C6E-9C14AB14F78B

P304

Q38844030-03446915-7A5E-4964-A920-92D241B31BDE

P31

Q38844030-70F90DBA-14B9-4C41-B2EE-9AB9C0919E99

P356

Q38844030-D68BD306-D0D3-44B6-AB05-800D826BF475

P433

Q38844030-BC328816-F788-4FA9-BC12-84C822A10B81

P478

Q38844030-B487C6B2-6B70-4253-B61E-5E4F723FA6D2

P577

Q38844030-9B9B2D94-949D-4A5A-8259-36192BA96828

P698

Q38844030-B2FFE692-E6D2-4D74-B970-E117A889E698

P356

P1433

International Journal of Cancer

P1476

Function and diagnostic value of Anosmin-1 in gastric cancer progression.

@en

P2093

Chie Tanaka

http://www.w3.org/2001/XMLSchema#string

Dai Shimizu

http://www.w3.org/2001/XMLSchema#string

Daisuke Kobayashi

http://www.w3.org/2001/XMLSchema#string

Goro Nakayama

http://www.w3.org/2001/XMLSchema#string

Haruyoshi Tanaka

http://www.w3.org/2001/XMLSchema#string

Hideki Takami

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Sugimoto

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Ezaka

http://www.w3.org/2001/XMLSchema#string

Masahiko Koike

http://www.w3.org/2001/XMLSchema#string

Michitaka Fujiwara

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1

SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities

Molecular mechanisms of epithelial-mesenchymal transition

Comprehensive molecular characterization of gastric adenocarcinoma

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

Molecular classification of gastric cancer: a new paradigm.

Gene-expression profiling of microdissected breast cancer microvasculature identifies distinct tumor vascular subtypes

Casein kinase 2 prevents mesenchymal transformation by maintaining Foxc2 in the cytoplasm.

FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.

P304

721-730

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.29803

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26270236

http://www.w3.org/2001/XMLSchema#string